サマリー

消化管間質腫瘍治療薬の世界市場 2022-2026 年
Technavioは消化管間質腫瘍治療薬市場を監視しており、2022-2026年の間に10億8000万ドルの成長が見込まれ、予測期間中にCAGR 5.97％で加速しています。当レポートでは、消化管間質腫瘍治療薬市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、老年人口の増加、治療薬の採用拡大、啓蒙活動の増加によって牽引されています。
消化管間質腫瘍治療薬市場の分析には、投与経路セグメントと地理的状況も含まれます。
Technavioの消化管間質腫瘍治療薬市場は、以下のように区分されています。
投与経路別
- 経口
- 非経口
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、再生療法の登場が、今後数年間の消化管間質腫瘍治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、強力なパイプラインと研究資金の増加は、市場の大規模な需要につながるでしょう。
Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。消化管間質腫瘍治療薬市場に関する当レポートは、以下の分野を対象としています。
- 消化管間質腫瘍の治療薬市場サイジング
- 消化管間質腫瘍の治療薬市場予測
- 消化管間質腫瘍治療薬市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Ascentage Pharma Group International、AB Science SA、Bayer AG、Blueprint Medicines Corp、Bristol Myers Squibb Co,Deciphera Pharmaceuticals Inc、Immunicum AB、NATCO Pharma Ltd.、Novartis AG、Pfizer Inc、住友ファーマ・オンコロジー株式会社、Sun Pharmaceutical Industries Ltd、Xencor Inc、およびArog Pharmaceuticals Inc.を含むベンダーがあります。また、消化管間質腫瘍治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/gastrointestinal-stromal-tumors-therapeutics-market-industry-analysis をご覧ください。
Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメータを分析し、複数の情報源からのデータを調査、合成、総括することで、市場の詳細な姿を提示します。業界の主要な影響力を持つ人物を特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、広範な一次および二次調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Route of Administration
o 5.1 Market segments
o Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
o 5.2 Comparison by Route of Administration
o Exhibit 26: Chart on Comparison by Route of Administration
o Exhibit 27: Data Table on Comparison by Route of Administration
o 5.3 Oral - Market size and forecast 2021-2026
o Exhibit 28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Oral - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Oral - Year-over-year growth 2021-2026 (%)
o 5.4 Parenteral - Market size and forecast 2021-2026
o Exhibit 32: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Route of Administration
o Exhibit 36: Market opportunity by Route of Administration ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 UK - Market size and forecast 2021-2026
o Exhibit 62: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 France - Market size and forecast 2021-2026
o Exhibit 70: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.11 Japan - Market size and forecast 2021-2026
o Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Ascentage Pharma Group International
o Exhibit 85: Ascentage Pharma Group International - Overview
o Exhibit 86: Ascentage Pharma Group International - Business segments
o Exhibit 87: Ascentage Pharma Group International - Key offerings
o Exhibit 88: Ascentage Pharma Group International - Segment focus
o 10.4 Bayer AG
o Exhibit 89: Bayer AG - Overview
o Exhibit 90: Bayer AG - Business segments
o Exhibit 91: Bayer AG - Key offerings
o Exhibit 92: Bayer AG - Segment focus
o 10.5 Blueprint Medicines Corp
o Exhibit 93: Blueprint Medicines Corp - Overview
o Exhibit 94: Blueprint Medicines Corp - Product / Service
o Exhibit 95: Blueprint Medicines Corp - Key news
o Exhibit 96: Blueprint Medicines Corp - Key offerings
o 10.6 Bristol Myers Squibb Co.
o Exhibit 97: Bristol Myers Squibb Co. - Overview
o Exhibit 98: Bristol Myers Squibb Co. - Product / Service
o Exhibit 99: Bristol Myers Squibb Co. - Key offerings
o 10.7 Deciphera Pharmaceuticals Inc
o Exhibit 100: Deciphera Pharmaceuticals Inc - Overview
o Exhibit 101: Deciphera Pharmaceuticals Inc - Business segments
o Exhibit 102: Deciphera Pharmaceuticals Inc - Key news
o Exhibit 103: Deciphera Pharmaceuticals Inc - Key offerings
o Exhibit 104: Deciphera Pharmaceuticals Inc - Segment focus
o 10.8 Immunicum AB
o Exhibit 105: Immunicum AB - Overview
o Exhibit 106: Immunicum AB - Business segments
o Exhibit 107: Immunicum AB - Key offerings
o Exhibit 108: Immunicum AB - Segment focus
o 10.9 Novartis AG
o Exhibit 109: Novartis AG - Overview
o Exhibit 110: Novartis AG - Business segments
o Exhibit 111: Novartis AG - Key offerings
o Exhibit 112: Novartis AG - Segment focus
o 10.10 Pfizer Inc.
o Exhibit 113: Pfizer Inc. - Overview
o Exhibit 114: Pfizer Inc. - Product / Service
o Exhibit 115: Pfizer Inc. - Key news
o Exhibit 116: Pfizer Inc. - Key offerings
o 10.11 Sun Pharmaceutical Industries Ltd
o Exhibit 117: Sun Pharmaceutical Industries Ltd - Overview
o Exhibit 118: Sun Pharmaceutical Industries Ltd - Product / Service
o Exhibit 119: Sun Pharmaceutical Industries Ltd - Key offerings
o 10.12 Xencor Inc.
o Exhibit 120: Xencor Inc. - Overview
o Exhibit 121: Xencor Inc. - Product / Service
o Exhibit 122: Xencor Inc. - Key news
o Exhibit 123: Xencor Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 124: Inclusions checklist
o Exhibit 125: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 126: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 127: Research methodology
o Exhibit 128: Validation techniques employed for market sizing
o Exhibit 129: Information sources
o 11.5 List of abbreviations
o Exhibit 130: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibits25: Data Table on Route of Administration - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Route of Administration
Exhibits27: Data Table on Comparison by Route of Administration
Exhibits28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Route of Administration ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Ascentage Pharma Group International - Overview
Exhibits86: Ascentage Pharma Group International - Business segments
Exhibits87: Ascentage Pharma Group International - Key offerings
Exhibits88: Ascentage Pharma Group International - Segment focus
Exhibits89: Bayer AG - Overview
Exhibits90: Bayer AG - Business segments
Exhibits91: Bayer AG - Key offerings
Exhibits92: Bayer AG - Segment focus
Exhibits93: Blueprint Medicines Corp - Overview
Exhibits94: Blueprint Medicines Corp - Product / Service
Exhibits95: Blueprint Medicines Corp - Key news
Exhibits96: Blueprint Medicines Corp - Key offerings
Exhibits97: Bristol Myers Squibb Co. - Overview
Exhibits98: Bristol Myers Squibb Co. - Product / Service
Exhibits99: Bristol Myers Squibb Co. - Key offerings
Exhibits100: Deciphera Pharmaceuticals Inc - Overview
Exhibits101: Deciphera Pharmaceuticals Inc - Business segments
Exhibits102: Deciphera Pharmaceuticals Inc - Key news
Exhibits103: Deciphera Pharmaceuticals Inc - Key offerings
Exhibits104: Deciphera Pharmaceuticals Inc - Segment focus
Exhibits105: Immunicum AB - Overview
Exhibits106: Immunicum AB - Business segments
Exhibits107: Immunicum AB - Key offerings
Exhibits108: Immunicum AB - Segment focus
Exhibits109: Novartis AG - Overview
Exhibits110: Novartis AG - Business segments
Exhibits111: Novartis AG - Key offerings
Exhibits112: Novartis AG - Segment focus
Exhibits113: Pfizer Inc. - Overview
Exhibits114: Pfizer Inc. - Product / Service
Exhibits115: Pfizer Inc. - Key news
Exhibits116: Pfizer Inc. - Key offerings
Exhibits117: Sun Pharmaceutical Industries Ltd - Overview
Exhibits118: Sun Pharmaceutical Industries Ltd - Product / Service
Exhibits119: Sun Pharmaceutical Industries Ltd - Key offerings
Exhibits120: Xencor Inc. - Overview
Exhibits121: Xencor Inc. - Product / Service
Exhibits122: Xencor Inc. - Key news
Exhibits123: Xencor Inc. - Key offerings
Exhibits124: Inclusions checklist
Exhibits125: Exclusions checklist
Exhibits126: Currency conversion rates for US$
Exhibits127: Research methodology
Exhibits128: Validation techniques employed for market sizing
Exhibits129: Information sources
Exhibits130: List of abbreviations